PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
PTC Therapeutics announces positive results from long-term treatment studies on vatiquinone for the treatment of Friedreich ataxia.…
…
Earnings call: PTC Therapeutics updates on Q2 2024 financials & trials…
…
NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC…
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
The dynamics of Friedreichs ataxia market are anticipated to change as companies across the globe are thoroughly working toward the…
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
PTC Therapeutics (PTCT) falls as the ECs advisory committee adopts a negative opinion regarding the renewal of the conditional marketing…
Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.…
…
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January…
…
Earnings call: PTC Therapeutics reports strong first quarter financials…
…
PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for…
Earnings call: PTC Therapeutics reports strong growth and pipeline progress…
…
…
PTC Therapeutics posts 35% revenue growth in 2023…
C4 Therapeutics Inc shares surged 93% to $2.28 in early trading on Tuesday after the clinical-stage biopharmaceutical company announced an…
…
…
…
Shares gain 12% as PTC says proceeds of deal will be used to retire debt…
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with…
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest…
While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the…
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -68.35% and 0.07%, respectively, for the quarter ended June 2023. Do…
– Second-quarter 2023 total revenue of $214 million, representing 29% year-over-year growth – – Positive APHENITY and PIVOT-HD data readouts…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
SOUTH PLAINFIELD, N.J., July 17, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Pierre Gravier…
SOUTH PLAINFIELD, N.J., July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics Shares Fall 21% as Co. Discontinues Some Programs in Gene Therapy...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-22...…
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-19...…
- Preclinical and early research gene therapy programs discontinued - - Expected reductions of approximately 15% in residual 2023 OPEX…
- Conference call and webcast to be held at 5:00 pm EDT - SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/…
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-18...…
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-17...…
- Highly statistically significant and clinically meaningful results - - 63% mean blood Phe reduction in primary analysis population (p...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…